HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Reaction

Hydrochloric Acid → (6R,7R)-3-(carbamoyloxymethyl)-7-[[2-(2-furanyl)-2-methoxyimino-1-oxoethyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

HRID 261148
Print

Reaction equation

HRID 261148 reaction equation
[OH:1][CH2:2][C:3]1[CH2:4][S:5][C@@H:6]2[C@H:13]([NH:14][C:15](=[O:25])[C:16](=[N:22][O:23][CH3:24])[C:17]3[O:18][CH:19]=[CH:20][CH:21]=3)[C:12](=[O:26])[N:7]2[C:8]=1[C:9]([OH:11])=[O:10].P([O-])([O-])([O:29][C:30](=O)[NH2:31])=O.P(OC[C@H]1O[C@@H](N2C3N=CN=C(N)C=3N=C2)[C@H](O)[C@@H]1O)(OP(OP(O)(O)=O)(O)=O)(=O)O.[Cl-].[Mg+2].[Cl-].[OH-].[K+].Cl>[Cl-].[Mn+2].[Cl-].C(O)(=O)C>[C:30]([O:1][CH2:2][C:3]1[CH2:4][S:5][C@@H:6]2[C@H:13]([NH:14][C:15](=[O:25])[C:16](=[N:22][O:23][CH3:24])[C:17]3[O:18][CH:19]=[CH:20][CH:21]=3)[C:12](=[O:26])[N:7]2[C:8]=1[C:9]([OH:11])=[O:10])(=[O:29])[NH2:31]
ParticipantsProcedureWorkupSources & evidenceReaction notes

Participants

9

Reactant 6

HCID 313Hydrochloric AcidHCID 59575'-AtpHCID 14797Potassium HydroxideHCID 3423467Carbamic acid, monoanhydride with phosphoric acid, ion(2-)HCID 5360315Magnesium ChlorideHCID 54170549(6R,7R)-3-Hydroxymethyl-7-[2-(fur-2-yl)-2-methoxyiminoacetamido]ceph-3-em-4-carboxylic acid

Product 1

HCID 41375(6R,7R)-3-(carbamoyloxymethyl)-7-[[2-(2-furanyl)-2-methoxyimino-1-oxoethyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

Reagents, catalysts & solvents 2

HCID 10313134Manganese(2+) dichlorideCatalystHCID 176Acetic AcidSolvent

Procedure

Concentrated enzyme (0.5 ml) was incubated at 28° in a final volume of 1.0 ml water containing (6R,7R)-3-hydroxymethyl-7-[2-methoxyimino-2-(fur-2-yl) acetamido]ceph-3-em-4-carboxylic acid (syn-isomer) (0,1 μmole), carbamoyl phosphate (3 μmoles), ATP (1 μmole), magnesium chloride (1 μmole), manganese chloride (1 μmole) & pipes buffer (50 μmoles) adjusted to pH 6.0 with potassium hydroxide. After 2 hr the reaction was stopped by the addition of acetic acid (20 μl). The pH was then adjusted to 2.0 with M hydrochloric acid and the precipitated protein was centrifuged off. The supernatant was extracted with ethylacetate (2.5 ml). The organic phase was collected and evaporated to dryness. The cephalosporins it contained were then separated by hplc [100 mm×5 diam. column Partisil 5 eluted at 1500 psi with chloroform:methanol:90% formic acid (25:2:1 v/v) saturated with water] and were detected by their absorption at 270 nm. Their retention time was compared with standard samples. The size of the U.V. absorbing peaks showed that 20% of the cephalosporin starting material had been converted to title compound.

Workup

  1. concentrationConcentrated enzyme (0.5 ml)
  2. customwas incubated at 28°
  3. extractionThe supernatant was extracted with ethylacetate (2.5 ml)
  4. customThe organic phase was collected
  5. customevaporated to dryness
  6. customThe cephalosporins it contained were then separated by hplc [100 mm×5 diam. column Partisil 5 eluted at 1500 psi with chloroform:methanol:90% formic acid (25:2:1 v/v) saturated with water]
  7. customwere detected by their absorption at 270 nm

Sources & evidence

ORD record
ord-deb97bd49c524110a64ea3ae885506b7
Source dataset
uspto-grants-1979_08
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US04164447

Reaction notes

On this pageParticipantsProcedureWorkupSources & evidenceReaction notes